Tag: R&D

  • L’aventure Google X : Explorations et Echecs dans l’Innovation

    L’aventure Google X : Explorations et Echecs dans l’Innovation

    Google X est devenue un symbole d’audace technologique avec son approche de ‘moonshot’, visant des avancées significatives par le biais de recherches et de développements ambitieux. Pourtant, malgré un nombre impressionnant de projets, Google X a souvent été marquée par des échecs et des annulations, ce qui soulève des questions sur l’efficacité et la rentabilité…

  • Profits Over Patients: The Dark Side of Big Pharma’s Accounting Practices

    Profits Over Patients: The Dark Side of Big Pharma’s Accounting Practices

    The pharmaceutical industry is often viewed through a dual lens. On one hand, it’s seen as a noble field focused on saving lives and innovating treatments for countless diseases. On the other, there’s undeniable corporate greed reminiscent of major Wall Street firms. This dichotomy shines brightly when examining the industry’s financial practices, especially concerning tax…

  • Apple and Environmental Standards: A Toxic Mix?

    Apple and Environmental Standards: A Toxic Mix?

    With its state-of-the-art devices and eco-friendly marketing, Apple has long reigned supreme in the tech world. However, recent reports suggest that even industry giants are not immune to regulatory scrutiny. The Environmental Protection Agency (EPA) has identified at least 19 potential violations at Apple’s facility in Santa Clara, California, focusing on improper labeling and handling…

  • When New Drugs Become A Luxury: Affordability Issues in Modern Medicine

    When New Drugs Become A Luxury: Affordability Issues in Modern Medicine

    The recent advancements in pharmaceuticals have undoubtedly been life-changing, but the question remains: how sustainable are these breakthroughs if they come with prohibitive price tags? It’s a dilemma that keeps recurring in the medical community and has been a hot topic among the general public. The core issue revolves around the affordability of cutting-edge medications.…

  • Mitsubishi’s Rubik’s Cube Robot: Innovation Beyond Speed

    Mitsubishi’s Rubik’s Cube Robot: Innovation Beyond Speed

    A remarkable leap in robotics has been achieved by Mitsubishi, with their cutting-edge robot solving a Rubik’s Cube in a breathtaking 0.305 seconds. This feat is not merely about solving a cube but demonstrates the incredible advancements in robotics technology. But let’s delve deeper than the surface level amazement—beyond this visceral display of speed and…

  • Apples store aktie-tilbagekøb – En Strategisk Manøvre eller et Tegn pÃ¥ Udfordringer?

    Apples store aktie-tilbagekøb – En Strategisk Manøvre eller et Tegn pÃ¥ Udfordringer?

    Apples nylige annoncering om et aktie-tilbagekøbsprogram pÃ¥ 110 milliarder dollars har rejst mange øjenbryn, særligt i lyset af det faktum, at firmaets seneste kvartalsrapport viste en nedgang i bÃ¥de profit og omsætning. Dette skridt kan ses som et forsøg pÃ¥ at genoprette investorernes tillid og oppuste aktiekursen, men det rejser ogsÃ¥ spørgsmÃ¥let om, hvorvidt disse…